Patents by Inventor Tadateru Hamada

Tadateru Hamada has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITION FOR TREATING FATTY LIVER DISEASE
    Publication number: 20230210822
    Abstract: Provided is a pharmaceutical composition for treating and/or preventing fatty liver disease, particularly nonalcoholic fatty liver disease, the pharmaceutical composition having an excellent ACC2-selective inhibitory action and having no side effects such as an increase in plasma triglyceride or a decrease in platelet concentration. A pharmaceutical composition for treating and/or preventing fatty liver disease, the pharmaceutical composition comprising a compound represented by Formula (I): wherein R1 is haloalkyl or non-aromatic carbocyclyl, R2 is a hydrogen atom or halogen, R3 is halogen, ring A is a group represented by the formula: -L1- is —O—(CH2)—, —(CH2)2—, or the like, R4 is alkyl or haloalkyl, and R5 is alkylcarbonyl or carbamoyl, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: May 20, 2021
    Publication date: July 6, 2023
    Applicant: Shionogi & Co., Ltd.
    Inventors: Hideo YUKIOKA, Atsuyuki SHIMAZAKI, Tadateru HAMADA, Naoki OHYABU
  • DIAGNOSTIC MARKER FOR CORONARY ARTERY DISEASE
    Publication number: 20180306821
    Abstract: The present invention pertains to the diagnosis of coronary artery disease. Specifically, the present invention pertains to the diagnosis of coronary artery disease using phosphatidylinositol (36:5) or lysophosphatidylinositol (20:5) as a molecular marker.
    Type: Application
    Filed: October 19, 2016
    Publication date: October 25, 2018
    Inventors: Takashi Ono, Tadateru Hamada, Shuhei Shigaki, Atsushi Morita